-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Strong collaboration, ushering in a new chapter together! Xi'an Zhuohong Chaoyuan Bio paid a visit to Keyuan Pharmaceutical, jointly exploring new opportunities for growth!
Publish Time:
2025-06-20
From June 18 to 19, Cai Yujie, founder and director of Xi'an Zhuohong Chaoyuan Biotechnology Co., Ltd., and his delegation visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. The two sides engaged in in-depth discussions covering production line construction, technology R&D, and market insights, laying the foundation for exploring new avenues of collaborative industrial development.
From June 18 to 19, Cai Yujie, founder and director of Xi'an Zhuohong Chaoyuan Biotechnology Co., Ltd., and his delegation visited Keyuan Pharmaceutical (stock code: 301281.SZ) for an inspection and exchange. The two sides engaged in in-depth discussions covering production line construction, technology R&D, and market insights, laying the foundation for exploring new pathways toward collaborative industrial development.
Xi'an Zhuohong Chaoyuan Biotechnology Co., Ltd. boasts outstanding strengths in the fields of synthetic biology research and product development, with its unique microbial strain application technology enabling differentiated competitiveness in the emerging health-related raw materials sector. Meanwhile, Keyuan Pharmaceutical relies on its large-scale production facilities and a robust, standardized manufacturing system, demonstrating strong capabilities in capacity scaling and streamlined operational practices.
This latest collaboration between the two parties focuses on the integrated demand for technological innovation and industrial implementation—combining Zhuohong Chaoyuan's R&D capabilities with Keyuan Pharmaceutical's industrialization resources to create a complementary partnership, opening up diverse opportunities for expanding product portfolios and tapping into broader market prospects.
During the inspection, the Zhuo Hong Chao Yuan team conducted an on-site investigation of Kexuan Pharmaceutical's production line construction. Both sides unanimously agreed that a flexible cooperation model could facilitate resource integration, accelerate the translation of technological achievements into market value, and jointly explore new opportunities for growth in fields such as the greater healthcare industry.
This collaboration highlights the exemplary effect of strong partnerships between upstream and downstream enterprises in the industrial chain. Building on this joint effort, both parties will continue to deepen their strategic synergy, embarking on comprehensive explorations in areas such as technological breakthroughs and product development—thus jointly ushering in a new chapter of growth and innovation.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline